Researchers from the 711th Human Performance Wing Airman Systems Directorate at Wright-Patterson Air Force Base, in collaboration with the National Institutes of Healt, Air Force Lifecycle Management Center (AFLCMC), and Ginkgo Bioworks, are investigating existing and emerging testing methods to determine the number of people with detectable COVID-19 antibodies, but no known exposure or confirmed clinical illness; and research how to leverage technological advancements to demonstrate methods of detecting active COVID-19 infection that can be scaled.
Sampling for the study will be done by researchers from the 711th Human Performance Wing in collaboration with Courtney Sulentic, an associate professor of the Department of Pharmacology and Toxicology and Mateen Rizki, professor and chair of the Department of Computer Science and Engineering.
About the Author